BIOMARIN PHARMACEUTICAL INC
Total Trades
105
Buys
1
Sells
62
Largest Trade
N/A
Insiders
13
Institutional Funds
451
Inst. Value
$1M+
Activist Filings
23
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Friberg Gregory R | EVP | SELL | $100K–$500K | 6K | $60.38 | Feb 27, 2026 |
| Davis George Eric | EVP | SELL | $1M+ | 26K | $61.36 | Feb 27, 2026 |
| Davis George Eric | EVP | GRANT | N/A | 15K | — | Feb 27, 2026 |
| Burkhart Erin | GVP | SELL | $100K–$500K | 2K | $59.31 | May 20, 2025 |
| Hubbard Cristin | EVP | GRANT | $1K–$15K | 273 | $54.14 | May 6, 2025 |
| Hubbard Cristin | EVP | SELL | $15K–$50K | 273 | $64.92 | May 6, 2025 |
| Burkhart Erin | GVP | SELL | $50K–$100K | 1K | $71.52 | Mar 20, 2025 |
| Burkhart Erin | GVP | SELL | $50K–$100K | 1K | $68.38 | Feb 26, 2025 |
| Guyer Charles Greg | EVP | GRANT | $1K–$15K | 55 | $56.01 | Nov 14, 2024 |
| Guyer Charles Greg | EVP | SELL | $100K–$500K | 5K | $66.37 | Nov 14, 2024 |
| Mueller Brian | CFO | GRANT | $15K–$50K | 300 | $68.65 | May 31, 2024 |
| Mueller Brian | CFO | EXERCISE | $100K–$500K | 5K | $63.10 | May 31, 2024 |
| Mueller Brian | CFO | SELL | $100K–$500K | 5K | $75.19 | May 31, 2024 |
| Davis George Eric | EVP | EXERCISE | $1M+ | 41K | $63.10 | May 30, 2024 |
| Davis George Eric | EVP | SELL | $1M+ | 41K | $74.51 | May 30, 2024 |
| BIENAIME JEAN JACQUES | Director | EXERCISE | $1M+ | 40K | $63.10 | Apr 15, 2024 |
| BIENAIME JEAN JACQUES | Director | SELL | $1M+ | 40K | $91.13 | Apr 15, 2024 |
| Burkhart Erin | GVP | SELL | $100K–$500K | 2K | $90.00 | Apr 12, 2024 |
| Davis George Eric | EVP | SELL | $1M+ | 25K | $88.34 | Apr 1, 2024 |
| BIENAIME JEAN JACQUES | Director | GRANT | N/A | 144K | — | Feb 29, 2024 |
| BIENAIME JEAN JACQUES | Director | SELL | $50K–$100K | 1K | $90.35 | Feb 29, 2024 |
| BIENAIME JEAN JACQUES | Director | EXERCISE | $1M+ | 30K | $63.10 | Feb 12, 2024 |
| BIENAIME JEAN JACQUES | Director | SELL | $1M+ | 30K | $89.03 | Feb 12, 2024 |
| BIENAIME JEAN JACQUES | Director | SELL | $500K+ | 10K | $93.99 | Dec 22, 2023 |
| BIENAIME JEAN JACQUES | Director | EXERCISE | $500K+ | 10K | $63.10 | Dec 22, 2023 |
| Ajer Jeffrey Robert | EVP | GRANT | $15K–$50K | 318 | $66.88 | Aug 17, 2023 |
| Ajer Jeffrey Robert | EVP | SELL | $100K–$500K | 5K | $90.00 | Aug 17, 2023 |
| FUCHS HENRY J | President | SELL | $1M+ | 12K | $90.43 | Aug 11, 2023 |
| Guyer Charles Greg | EVP | SELL | $500K+ | 5K | $93.30 | Aug 10, 2023 |
| Davis George Eric | EVP | SELL | $500K+ | 11K | $89.42 | Aug 9, 2023 |
| BIENAIME JEAN JACQUES | CEO | SELL | $500K+ | 10K | $88.21 | Aug 9, 2023 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $1M+ | 30K | $67.81 | May 15, 2023 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 30K | $94.67 | May 15, 2023 |
| BIENAIME JEAN JACQUES | CEO | GRANT | $15K–$50K | 317 | $66.88 | May 11, 2023 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $1M+ | 60K | $67.81 | May 11, 2023 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 60K | $94.89 | May 11, 2023 |
| BIENAIME JEAN JACQUES | CEO | SELL | $500K+ | 10K | $99.56 | Apr 12, 2023 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $500K+ | 10K | $67.81 | Apr 12, 2023 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $500K+ | 10K | $67.81 | Apr 10, 2023 |
| BIENAIME JEAN JACQUES | CEO | SELL | $500K+ | 10K | $96.13 | Apr 10, 2023 |
| LAWLIS V BRYAN | Director | EXERCISE | $500K+ | 9K | $67.81 | Apr 4, 2023 |
| LAWLIS V BRYAN | Director | SELL | $500K+ | 9K | $97.09 | Apr 4, 2023 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 23K | $91.64 | Mar 14, 2023 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $1M+ | 23K | $67.81 | Mar 14, 2023 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $1M+ | 21K | $67.81 | Feb 15, 2023 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 21K | $109.84 | Feb 15, 2023 |
| Ajer Jeffrey Robert | EVP | EXERCISE | $1M+ | 49K | $67.81 | Jan 28, 2023 |
| Ajer Jeffrey Robert | EVP | SELL | $1M+ | 49K | $115.70 | Jan 28, 2023 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $1M+ | 20K | $67.81 | Jan 19, 2023 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 20K | $111.90 | Jan 19, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 451 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DODGE & COX | 14.6M | $1M+ | SH |
| PRIMECAP MANAGEMENT CO/CA/ | 14.5M | $1M+ | SH |
| NORGES BANK | 7.5M | $1M+ | SH |
| STATE STREET CORP | 7.5M | $1M+ | SH |
| VIKING GLOBAL INVESTORS LP | 6.0M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 3.0M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 2.9M | $1M+ | SH |
| Capital Research Global Investors | 2.5M | $1M+ | SH |
| Deep Track Capital, LP | 2.3M | $1M+ | SH |
| Squarepoint Ops LLC | 1.8M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.4M | $1M+ | SH |
| Assenagon Asset Management S.A. | 1.4M | $1M+ | SH |
| DnB Asset Management AS | 1.4M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.3M | $1M+ | SH |
| Soleus Capital Management, L.P. | 1.3M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.3M | $1M+ | SH |
| FIRST TRUST ADVISORS LP | 1.2M | $1M+ | SH |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 1.0M | $1M+ | SH |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1.1M | $1M+ | SH |
| Brandywine Global Investment Management, LLC | 946K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jan 21, 2026
9.1%
17.6M shares
SC 13G/A · Nov 14, 2025
4.3%
8.3M shares
SC 13G/A · Aug 14, 2025
6.4%
12.3M shares
SC 13G/A · Aug 14, 2025
8.2%
15.8M shares
Capital Research Global Investors
SC 13G/A · May 13, 2025
4.8%
9.2M shares
SC 13G/A · Apr 29, 2025
10.8%
20.6M shares
Capital Research Global Investors
SC 13G/A · Feb 13, 2025
6.8%
13.0M shares
SC 13G · Sep 30, 2024
5.1%
9.8M shares
The Vanguard Group - 23-1945930
SC 13G/A · Jul 10, 2024
10.0%
19.0M shares
SC 13G/A · Jul 8, 2024
12.0%
22.8M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.6%
18.0M shares
SC 13G/A · Feb 13, 2024
7.4%
1.4B shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 12, 2024
9.8%
18.4M shares
Capital Research Global Investors 95-1411037
SC 13G · Feb 9, 2024
5.7%
10.8M shares
SC 13G/A · Jan 26, 2024
7.8%
14.7M shares
SC 13G/A · Feb 14, 2023
7.7%
14.4M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Feb 13, 2023
3.0%
5.7M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 9, 2023
9.5%
17.6M shares
SC 13G/A · Feb 3, 2023
8.2%
15.2M shares
SC 13G/A · Mar 11, 2022
7.6%
14.0M shares
SC 13G/A · Feb 14, 2022
8.1%
14.8M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 10, 2022
9.7%
17.8M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Jan 10, 2022
6.9%
12.7M shares